KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EBT (2016 - 2025)

Historic EBT for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $328.0 million.

  • Quest Diagnostics' EBT rose 1081.08% to $328.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1563.34%. This contributed to the annual value of $1.2 billion for FY2024, which is 398.23% up from last year.
  • Latest data reveals that Quest Diagnostics reported EBT of $328.0 million as of Q3 2025, which was up 1081.08% from $384.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' EBT registered a high of $817.0 million during Q2 2021, and its lowest value of $109.0 million during Q4 2022.
  • Over the past 5 years, Quest Diagnostics' median EBT value was $317.0 million (recorded in 2023), while the average stood at $375.1 million.
  • Its EBT has fluctuated over the past 5 years, first surged by 43050.85% in 2021, then tumbled by 7828.69% in 2022.
  • Over the past 5 years, Quest Diagnostics' EBT (Quarter) stood at $502.0 million in 2021, then tumbled by 78.29% to $109.0 million in 2022, then skyrocketed by 117.43% to $237.0 million in 2023, then grew by 26.16% to $299.0 million in 2024, then rose by 9.7% to $328.0 million in 2025.
  • Its last three reported values are $328.0 million in Q3 2025, $384.0 million for Q2 2025, and $276.0 million during Q1 2025.